Inventor · disambiguated record
Bo Åkerström
Also filed as: AKERSTROEM BO · AKERSTROM BO · AKERSTRÖM BO · ÅKERSTROM BO
7 granted patents·5 pending applications·20 citations·filing 1999–2018
78Inventor score
Top patents by PatentIndex Score
12 records- 0177US8568999B2Diagnosis and treatment of preeclampsiaHANSSON STEFAN·Filed 2008·Granted Oct 29, 2013·5 cites·6 claims
- 0267US10981963B2Alpha-1-microglobulin derived proteins and their useGUARD THERAPEUTICS INT AB·Filed 2017·Granted Apr 20, 2021·2 cites·10 claims
- 0360US10350268B2Medical use of the radical scavenger and antioxidant alpha-1-microglobulinÅKERSTROEM BO·Filed 2009·Granted Jul 16, 2019·1 cites·28 claims
- 0455US10359406B2Diagnosis and treatment of preeclampsiaA1M PHARMA AB·Filed 2018·Granted Jul 23, 2019·0 cites·15 claims
- 0555US6380365B1Temperature dependent ligand facilitated purification of proteinsAFFITECH AS·Filed 1999·Granted Apr 30, 2002·12 cites·23 claims
- 0649US2014065170A1Diagnosis and treatment of preeclampsiaA1M PHARMA AB·Filed 2013·Application pending·0 cites
- 0742US10960048B2Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapyGUARD THERAPEUTICS INT AB·Filed 2016·Granted Mar 30, 2021·0 cites·11 claims
- 0835US2013122529A1HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIAAKERSTROM BO·Filed 2011·Application pending·0 cites
- 0933US2019054142A1Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast mediaA1M PHARMA AB·Filed 2017·Application pending·0 cites
- 1030US2018074070A1Biomarkers for preeclampsiaA1M PHARMA AB·Filed 2016·Application pending·0 cites
- 1130US2020345810A1Use of alpha-1-microglobulin for protection of bone marrow cellsGUARD THERAPEUTICS INT AB·Filed 2018·Application pending·0 cites
- 1229US10226507B2Alpha-1-microglobulin for use in the treatment of mitochondria-related diseasesA1M PHARMA AB·Filed 2013·Granted Mar 12, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Bo Åkerström files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →